نتائج البحث - "Assen Dudov"

1

دورية أكاديمية

Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice

المؤلفون: Manoela Manova, Jeliazko Arabadjiev, Radoslav Mangaldzhiev, Assen Dudov, Daniel Penchev, Margit Hemetsberger, Arkadi Sharkov, Boryana Zidarova, Dimitrina Apostolova, Maria Vasileva, Silvia Terezova, Mila Vlaskovska, Alexandra Savova

المصدر: Biotechnology & Biotechnological Equipment, Vol 37, Iss 1 (2023)

مصطلحات موضوعية: Ribociclib, breast cancer, Bulgaria, real-world data, outcomes, Biotechnology, TP248.13-248.65

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1310-2818; https://doaj.org/toc/1314-3530

URL الوصول: https://doaj.org/article/92ac34f305ed40eebf4528bee4735acc

PDF full text from Publisher

Find this article in full text from ProQuest

Full Text Finder

2

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN)

المؤلفون: Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Oleksandr Voitko, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Kazarnowicz, György Losonczy, Nikolay V Conev, Jon Armstrong, Natalie Byrne, Norah Shire, Haiyi Jiang, Jonathan W Goldman, Emilio Batagelj, Ignacio Casarini, Anea Viviana Pastor, Susana Noemi Sena, Juan Jose Zarba, Otto Burghuber, Sylvia Hartl, Bernd Lamprecht, Michael Studnicka, Luis Alberto Schlittler, Fabricio Augusto Martinelli de Oliveira, Aknar Calabrich, Gustavo Colagiovanni Girotto, Peo Dos Reis, Carlos Fausto Nino Gorini, Peo Rafael Martins De Marchi, Clarissa Serodio da Rocha Baldotto, Claudia Sette, Mauro Zukin, Assen Dudov, Rumyana Ilieva, Krassimir Koynov, Rositsa Krasteva, Ivan Tonev, Spartak Valev, Violetka Venkova, Minghong Bi, Chengshui Chen, Yuan Chen, Zhendong Chen, Jian Fang, Jifeng Feng, Zhigang Han, Jie Hu, Yi Hu, Wei Li, Zongan Liang, Zhong Lin, Rui Ma, Shenglin Ma, Kejun Nan, Yongqian Shu, Kai Wang, Mengzhao Wang, Gang Wu, Nong Yang, Zhixiong Yang, Helong Zhang, Wei Zhang, Jun Zhao, Yanqiu Zhao, Caicun Zhou, Jianying Zhou, Xiangdong Zhou, Vitezslav Kolek, Leona Koubkova, Jaromir Roubec, Jana Skrickova, Milada Zemanova, Christos Chouaid, Werner Hilgers, Hervé Lena, Denis Moro-Sibilot, Gilles Robinet, Pierre-Jean Souquet, Jürgen Alt, Helge Bischoff, Christian Grohe, Eckart Laack, Susanne Lang, Jens Panse, Christian Schulz, Krisztina Bogos, Eszter Csánky, Anea Fülöp, Zsolt Horváth, Judit Kósa, Ibolya Laczó, Gábor Pajkos, Zsuzsanna Pápai, Zsolt Pápai Székely, Veronika Sárosi, Attila Somfay, Éva Somogyiné Ezer, Anás Telekes, Jair Bar, Maya Gottfried, Norman Isaac Heching, Alona Zer Kuch, Roberta Bartolucci, Anna Cecilia Bettini, Angelo Delmonte, Marina Chiara Garassino, Mauro Minelli, Fausto Roila, Shinji Atagi, Koichi Azuma, Hisatsugu Goto, Koichi Goto, Yu Hara, Hidetoshi Hayashi, Toyoaki Hida, Kenya Kanazawa, Shintaro Kanda, Young Hak Kim, Shoichi Kuyama, Tadashi Maeda, Masahiro Morise, Yasuharu Nakahara, Makoto Nishio, Naoyuki Nogami, Isamu Okamoto, Haruhiro Saito, Masahiro Shinoda, Shigeki Umemura, Tatsuya Yoshida, Niels Claessens, Robin Cornelissen, Lizza Heniks, Jeroen Hiltermann, Egbert Smit, Agnes Staal van den Brekel, Dariusz Kowalski, Slawomir Mańdziuk, Robert Mróz, Marek Wojtukiewicz, Tudor Ciuleanu, Doina Ganea, Anei Ungureanu, Alexander Luft, Vladimir Moiseenko, Dina Sakaeva, Alexey Smolin, Alexander Vasilyev, Lyubov Vladimirova, Igor Anasina, Jozef Chovanec, Pavol Demo, Robert Godal, Peter Kasan, Marian Stresko, Michal Urda, Eun Kyung Cho, Joo-Hang Kim, Sang-We Kim, Gyeong-Won Lee, Jong-Seok Lee, Ki Hyeong Lee, Kyung Hee Lee, Yun Gyoo Lee, Maria Amelia Insa Molla, Manuel Domine Gomez, Juan Ignacio Delgado Mingorance, Dolores Isla Casado, Marta Lopez Brea, Margarita Majem Tarruella, Teresa Morán Bueno, Alejano Navarro Mendivil, Luis Paz-Ares Rodríguez, Santiago Ponce Aix, Maria Rosario Garcia Campelo, Gee-Chen Chang, Yen-Hsun Chen, Chao-Hua Chiu, Te-Chun Hsia, Kang-Yun Lee, Chien-Te Li, Chin-Chou Wang, Yu-Feng Wei, Shang-Yin Wu, Ahmet Alacacıoğlu, Irfan Çiçin, Ahmet Demirkazik, Mustafa Erman, Tuncay Göksel, Hryhoriy Adamchuk, Oleksii Kolesnik, Anna Kryzhanivska, Yuriv Ostapenko, Serhii Shevnia, Yaroslav Shparyk, Grygorii Ursol, Nataliia Voitko, Ihor Vynnychenko, Sunil Babu, Anne Chiang, Winston Chua, Shaker Dakhil, Afshin Dowlati, Basir Haque, Rodney Jamil, Jeanna Knoble, Shailena Lakhanpal, Kailhong Mi, Petros Nikolinakos, Steven Powell, Helen Ross, Eric Schaefer, Jeffrey Schneider, Joseph Spahr, David Spigel, Joseph Stilwill, Christopher Sumey, Michael Williamson

المصدر: The Lancet. 394(10212):1929-1939

مصطلحات موضوعية: Male, medicine.medical_specialty, Lung Neoplasms, Durvalumab, Population, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Gastroenterology, Drug Administration Schedule, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, Antineoplastic Agents, Immunological, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, 030212 general & internal medicine, Progression-free survival, education, Etoposide, Aged, education.field_of_study, Performance status, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, Interim analysis, Antineoplastic Agents, Phytogenic, Small Cell Lung Carcinoma, Progression-Free Survival, chemistry, Female, Cisplatin, Prophylactic cranial irradiation, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317c16284ac18a580a61a7c59b1e6e37
http://www.scopus.com/inward/record.url?scp=85075219567&partnerID=8YFLogxK

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

3

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

المؤلفون: A. Rusyn, Igor Bondarenko, Ahsan M. Arozullah, Martin Schuler, Assen Dudov, G. Manikhas, Daniel Maurus, Florian Lordick, Igor Bazin, S.-E. Al-Batran, Ugur Sahin, Christoph Huber, Kai Wiechen, Karl Dhaene, Jung Wook Park, Ö. Türeci, Ihor Vynnychenko, Bohuslav Melichar

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 32(5)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c486233e2bef686a8f665be8dfb76b53
https://pubmed.ncbi.nlm.nih.gov/33677015

4

Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma : Updated results from the FAST trial

المؤلفون: Martin Schuler, Assen Dudov, Salah-Eddin Al-Batran, Özlem Türeci, Andriy Rusyn, Florian Lordick, Daniel Maurus, Kai Wiechen, Igor Bondarenko, Igor Bazin, Karl Dhaene, Bohuslav Melichar, Georgy M. Manikhas, Ihor Vynnychenko, Ugur Sahin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d7f3f1ace08a055530b511c8f75af1

5

Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers : Results from the FAST study

المؤلفون: Karl Dhaene, Salah-Eddin Al-Batran, Bohuslav Melichar, Georgy M. Manikhas, Assen Dudov, Ihor Vynnychenko, Florian Lordick, Kai Wiechen, Martin Schuler, Özlem Türeci, Zanete Zvirbule, Daniel Maurus, Andriy Rusyn, Igor Bazin, Ugur Sahin

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Tight junction, business.industry, Medizin, Gastroesophageal Junction, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, Gastric mucosa, Medicine, Claudin, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f9e82e7db95b882e2b482527f286d5

6

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkinʼs Lymphoma or Multiple Myeloma

المؤلفون: Nashat Gabrail, David I. Quinn, Milin Acharya, Jyotsna Fuloria, Kai Chan, John Nemunaitis, Assen Dudov, Lorrin Yee, Nadine Cohen, Carolyn D. Britten

المصدر: Clinical Pharmacokinetics. 48:199-209

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b598f1e199ff70da9d6425bafd8713a
https://doi.org/10.2165/00003088-200948030-00006

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

7

220O Claudin 18.2 - a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer

المؤلفون: M. Nechaeva, Assen Dudov, Martin Schuler, A. Rusyn, G. Manikhas, Florian Lordick, A. Pecheniy, Ugur Sahin, Igor Bondarenko, O. Tu¨ reci, Igor Bazin, E. Gotovkin, Bohuslav Melichar, Zanete Zvirbule, Ihor Vynnychenko, N. Fadeeva, Y. Vinnyk, Christoph Huber, S.-E. Al-Batran

المصدر: Annals of Oncology. 27:ix69

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d5da5cb37adefcc03255e9e61be295b
https://doi.org/10.1016/s0923-7534(21)00377-x

8

FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma

المصدر: Journal of Clinical Oncology. 34:LBA4001-LBA4001

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2f9f7babf7a4da78ea88a25a470619
https://doi.org/10.1200/jco.2016.34.18_suppl.lba4001

تنقيح النتائج